![Mark Hollywood](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Hollywood
Directeur des opérations chez
ZYMEWORKS INC.
Fortune : 3 M $ au 31/07/2026
Profil
Mark Hollywood is currently EVP & Head-Technical & Manufacturing Operations at Zymeworks BC, Inc. since 2019.
Mr. Hollywood is also Chief Operating Officer & Executive Vice President at Zymeworks, Inc., with the COO & EVP title starting in 2026.
Formerly, Mr. Hollywood was Vice President & Head-ZymoGenetics at Bristol Myers Squibb Co. from 2010 to 2019.
Mr. Hollywood was Director-Quality Assurance & Quality Control at CellCyte Genetics Corp.
Mr. Hollywood completed undergraduate education at Western Illinois University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZYMEWORKS INC. 0,18 % | 06/07/2026 | 133 852 ( 0,18 % ) | 3 M $ | 31/07/2026 |
Postes actifs de Mark Hollywood
| Sociétés | Poste | Début |
|---|---|---|
| ZYMEWORKS INC. | Directeur des opérations | 09/01/2026 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Directeur Technique/Scientifique/R&D | 30/04/2019 |
Anciens postes connus de Mark Hollywood
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2019 |
| CELLCYTE GENETICS CORPORATION | Corporate Officer/Principal | - |
Formation de Mark Hollywood
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
CellCyte Genetics Corp.
 CellCyte Genetics Corp. Miscellaneous Commercial ServicesCommercial Services Develops stem cell therapeutic products | Commercial Services |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
Western Illinois University
 Western Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
